Noxopharm (ASX: NOX) is pleased to announce details of its 2019 Annual General Meeting to the market.
In addition to voting formalities, the Chair of the Board will present an overview of the year’s activities, achievements and plans for the year ahead. A clinical program and research update also will be provided.
For more information, download the attached PDF.
Download this document
